Terpos E, Kastritis E, Delimpasi S, Papathanasiou K, Labropoulou V, Kanellias N, Stathopoulos I, Migkou M, Solia E, Theodorakakou F, Papaiakovou E, Kotsopoulou M, Katodritou E, Gavriatopoulou M, Dimopoulos M. P13 | ISATUXIMAB WITH BORTEZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE FOLLOWED BY ISATUXIMAB AND LENALIDOMIDE MAINTENANCE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH SEVERE RENAL IMPAIRMENT: FINAL ANALYSIS OF A PHASE 2 STUDY BY GREEK MYELOMA STUDY GROUP. Haematologica 2026; 111(s2); https://doi.org/10.3324/haematol.2026.s2.14108.